Metropolis Healthcare $174 million IPO over subscribed

Published On 2019-04-06 03:36 GMT   |   Update On 2019-04-06 03:36 GMT

New Delhi: Metropolis Healthcare Ltd's initial public offering (IPO) to raise as much as 12.04 billion rupees ($174.01 million)was oversubscribed 5.8 times at the end of the book-running process, stock exchange data showed on Friday.


Of the 13.7 million shares the Indian diagnostics company intends to sell, promoter Sushil Kanubhai Shah will give up 6.3 million shares, while investor CA Lotus Investments, a unit of U.S.-based private equity firm Carlyle Group, will offload 7.4 million shares.


The IPO includes an anchor portion of about 6 million shares.


Read Also: Metropolis Healthcare gets SEBI nod, moves for Initial Public Offer


Of the remaining shares, investors bid for about 44.6 million shares in the company, or 5.8 times the 7.7 million on offer, as of 0115 GMT.


Interest for Indian equities has seen a rise recently as the country heads for its general elections next week, amid hopes that the current coalition government led by Prime Minister Narendra Modi would return to power, even though investors continued to maintain a cautious stance.


Read Also: Metropolis Healthcare to aim for Rs 2000 crore plus IPO: Report


Over the last month, India's state-owned Rail Vikas Nigam Ltd and the first ever real estate investment trust in India, Embassy Office Parks REIT have seen successful subscriptions.

Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News